International Journal of Medical and Pharmaceutical Research
2026, Volume-7, Issue 2 : 3347-3353
Research Article
Negative Pressure Wound Therapy with Delayed Closure Versus Primary Closure in Perforation Peritonitis: A Randomized Controlled Trial
 ,
 ,
 ,
Received
March 17, 2026
Accepted
April 7, 2026
Published
April 23, 2026
Abstract

Background: Perforation peritonitis is a serious surgical emergency due to heavy intra-abdominal contamination and a high incidence of postoperative surgical site infections (SSIs). Conventional primary closure of such contaminated laparotomy wounds often entraps bacteria, resulting in wound disruption.

Objectives: To compare clinical efficacy of NPWT with delayed wound closure and primary wound closure on SSI rates and healing in patients undergoing surgery for perforation peritonitis.

Material and Methods: A prospective randomized controlled trial was performed on 60 patients (30 in each arm) who developed perforation peritonitis and presented for emergency laparotomy. After source control, the NPWT cohort were managed with continuous sub-atmospheric pressure (-125 mmHg) for three days followed by standard dressings, and the control cohort underwent immediate primary closure. Primary end points were SSI incidence, epithelialization time, and infection relative risk.

Results: The baseline demographic and operative parameters were similar between groups. NPWT group had a significantly lower rate of surgical site infection (SSI) than conventional primary closure group (13.3% vs 43.3%, p = 0.010). In addition, NPWT effectively obstructed superficial SSIs and promoted rapid epithelialization (p = 0.019). The relative risk of developing an SSI in the NPWT cohort was 0.308 (95% CI: 0.113–0.836, p = 0.022) indicating a decrease of 69% in the probability to experience an infection.

Conclusion: NPWT with delayed closure was found to be a very effective, safe alternative of Primary Closure in Perforation peritonitis. It greatly reduces SSI risk and improves tissue healing without increasing the rate of other wound complications.

Keywords
INTRODUCTION

Perforation peritonitis has, unfortunately, remained a major and common surgical emergency most often due to hollow viscus perforation leading to massive gastrointestinal spillage in the peritoneal cavity. Despite modern advances in critical care and effective antimicrobial therapy, this condition is associated with significant morbidity that is particularly influenced by postoperative wound complications.1 Emergency laparotomy incisions in these circumstances are inherently categorized as contaminated or dirty, placing the surgical site at risk for high bacterial inoculums and severe systemic inflammatory responses. As a result, surgical site infections (SSIs) occur in 30% to 60% of these patients and cause delayed healing, fascial dehiscence, and prolonged hospital stays.2

 

The conventional standard of care entails closure of the wound primarily after the laparotomy; however, sealing a contaminated surgical field inevitably locks in place necrotic debris and bacterial organisms within a hypoxic environment that actively favours ongoing microbial growth and purulent exudate generation.3  In order to overcome these negative physiological conditions, Negative Pressure Wound Therapy (NPWT) or vacuum-assisted closure, has evolved as a dynamic wound modulation therapy. NPWT continuously evacuated infected exudates by control of sub-atmospheric pressure, decreased interstitial oedema, and mechanically stimulated local microcirculation to form robust granulation tissue.4 Although the use of prophylactic NPWT has demonstrated benefits in clean-contaminated surgeries, its effects on perforation peritonitis highly septic environment have not been specifically assayed. This study is a randomized controlled trial designed to determine whether NPWT followed by delayed closure provides improved wound healing and reduced relative risk for SSI compared to conventional primary closure in a tertiary care setting.

 

MATERIALS AND METHODS

Study Design and Setting:

This prospective randomized controlled trial was carried out over a period of one year at the Department of Surgery, M.G.M. Medical College and M.Y. Hospital, Indore, a high-volume tertiary care teaching institution. The study followed the institutional ethical guidelines and was approved formally.

 

Study Population:

Sample size calculation was based upon the expected differences in event proportions between the two study arms, using the following formula for comparing two independent proportions: n= (Zα+Z β)2 (P1Q1 + P2Q2)/(P1-P2)2, where Q1=100-P1 and Q2=100-P2, at a 90% statistical power (Zβ = 1.28) at a 95% confidence level (Zα = 1.96), projecting outcomes to be 13.7% (P1) in the NPWT cohort and 50.0% (P2) in the conventional cohort, where Q1=100-P1 and Q2=100-P2. Based on this statistical calculation, a minimum of 29.34 subjects per arm were necessary and thus 30 patients for each cohort were deemed adequate resulting in an overall sample size of 60 subjects.

 

Thus, the trial randomized 60 adult patients (>18 years old) admitted for emergency abdominal surgery with closed laparotomy wounds. Exclusion criteria included allergies to NPWT dressing materials, history of abdominal surgeries at any site, pre-existing surgical site infection and refusal for informed consent. Eligible patients were prospectively randomized into two equal cohorts of 30 patients each: Group A (NPWT + delayed wound closure) and Group B (Conventional primary wound closure).

 

Surgical Procedure and Intervention:

All participants had a standard exploratory laparotomy. After adequate intra-abdominal source control and peritoneal lavage, the fascial layer (rectus sheath) was approximated.

 

  • NPWT Protocol (Group A): Subcutaneous tissue and skin left open. After placing a protective layer over the surrounding skin, the entire infiltration site was covered with gauze impregnated with chlorhexidine, located directly over the fascial incision. Microporous polyurethane sponge-loaded customized suction evacuation drain was placed into the wound cavity. An occlusive adhesive drape was placed over the entire assembly in a hermetic manner. Negative pressure at -125 mmHg was continuously applied. The NPWT device was removed on the 3rd postoperative day and conventional dry dressings were used to manage the wound until delayed closure was feasible. (Figure 1 and 2)

 

  • Control Group (Group B): The surgical wound was primarily closed and dressed with povidone-iodine ointment and dry sterile gauze, which was changed daily according to the standard ward protocols.

 

Operational Definitions and Follow-up

  • Surgical Site Infection (SSI): Defined according to the standardized surveillance criteria of the Centre for Disease Control and Prevention as an infection at the surgical incision occurring within 30 days of surgery; further categorized as superficial (involving skin/subcutaneous tissue) or deep (involving fascial/muscle layer) infections.5
  • Delayed Primary Closure: A technique in which all contaminated skin and subcutaneous tissues are left open after laparotomy for continuous drainage and reduced inflammatory load, followed by surgical approximation when healthy granulation tissue has developed.6

 

Patients were closely followed up on postoperative day 14, 21, and 30 endpoints such as presence of surgical site infection (SSI), epithelialization time, wound dehiscence seroma formation and cosmetic scores. Data were entered in Microsoft Excel and statistically analysed through JAMOVI statistical software. Continuous data were presented as mean ± standard deviation or median with interquartile range. Categorical variables were reported as frequencies and percentages. Chi-square test or Fisher’s exact test were used to compare the two study groups for categorical variables. P values less than 0.05 were considered statistically significant.

Figure 1: Wound after application of Negative Pressure Dressing

 

Figure 2: Showing wound immediately after removing the NPWT dressing at post-operative day 3

 

RESULTS

The baseline socio-demographic and clinical characteristics of the 60 study participants are illustrated in Table 1. There were no statistically significant variations in mean age, gender demographic, or systemic comorbidities between the Negative Pressure Wound Therapy (NPWT) and traditional primary closure cohorts. Moreover, perforation aetiology and intraoperative peritoneal contamination degree showed a similar distribution within both groups; thus preventing pre-existing physiological and anatomical factors from confounding the post-operative healing outcomes.

 

Table 2 describes the preoperative laboratory parameters and the mean times of surgical procedures. Despite comparable haemoglobin concentrations, serum albumin levels and total operative times between the two study arms, more patients in the NPWT cohort had significantly higher baseline white blood cell (WBC) counts (p = 0.048). This increased leucocytosis suggests a significantly greater baseline systemic inflammatory and infectious load in the intervention group before source control was achieved surgically.

 

The incidence and anatomic depth of SSIs in surgeries performed by individual groups are summarized in Table 3 and Figure 3. NPWT resulted in a significant reduction in overall SSI rates (13.3% v 43.3% for the conventional primary closure group) (p = 0.010). Essentially, the NPWT protocol virtually eliminated superficial incisional infections and modulated deep fascial infection spread, signifying an enormous significance in preventing tissue injury at the incision microenvironment level.

 

The relative risk (RR) analysis for the development of postoperative wound infections is shown in Table 4 and in Figure 4. Statistical analysis yielded an RR of 0.308 (95% CI: 0.113–0.836); p = 0.022. The strong evidence while using this quantitative measure is that sub-atmospheric pressure therapy followed by delayed fascial approximation achieved a remarkable 69% relative reduction in infection risk compared to immediate primary wound closure.

 

Table 5 illustrates differences in the postoperative healing dynamics, showcasing the time needed for full epithelialization between treatment cohorts. Our study shows that patients treated under the NPWT protocol exhibited a significant increase in epithelialization scores compared to those managed by traditional methods (p = 0.019), indicating that NPWT is more effective and result-getting than conventional management. In light of these data, the perpetuation of a stable wound bed may suggest that controlled negative pressure directly promotes stabilization of any exuding factors that deter cellular proliferation necessary for optimal epidermal repair.

 

Table 1: Baseline Socio-demographic and Clinical Characteristics

Parameter

NPWT Cohort (n = 30)

Conventional Cohort (n = 30)

p-value

Age (years), Mean ± SD

52.87 ± 15.43

46.30 ± 18.36

0.139

Sex, n (%)

 

 

 

Male

17 (58.6%)

12 (41.4%)

0.196

Female

13 (41.9%)

18 (58.1%)

Primary Diagnosis, n (%)

 

 

 

Peptic Perforation

8 (47.1%)

9 (52.9%)

0.985

Ileal Perforation

9 (50.0%)

9 (50.0%)

Appendicular Perforation

7 (50.0%)

7 (50.0%)

Others

6 (54.5%)

5 (45.5%)

Comorbidities Present, n (%)

18 (58.1%)

13 (41.9%)

0.196

Contamination Grade, n (%)

 

 

 

Mild

5 (33.3%)

10 (66.7%)

0.286

Moderate

12 (60.0%)

8 (40.0%)

Severe

13 (52.0%)

12 (48.0%)

Table 2: Preoperative Laboratory Parameters and Operative Duration

Parameter

NPWT Cohort (Mean ± SD)

Conventional Cohort (Mean ± SD)

p-value

Hemoglobin (g/dL)

11.44 ± 1.67

11.72 ± 1.52

0.506

Albumin (g/dL)

3.66 ± 0.42

3.81 ± 0.41

0.179

WBC Count (cells/mm³)

11,991.47 ± 2,664.67

10,611.17 ± 2,627.19

0.048

Operative Time (min)

118.23 ± 25.16

113.03 ± 25.67

0.431

 

Table 3: Incidence and Typology of Surgical Site Infection (SSI)

SSI Classification

NPWT Cohort (n = 30)

Conventional Cohort (n = 30)

p-value

Overall SSI Incidence, n (%)

4 (13.3%)

13 (43.3%)

0.010

SSI Typology

 

 

 

No Infection

26 (86.7%)

17 (56.7%)

0.013

Superficial SSI

0 (0.0%)

6 (20.0%)

Deep SSI

4 (13.3%)

7 (23.3%)

 

Figure 3: Incidence and Depth of Surgical Site Infection by Treatment Group

 

Table 4: Relative Risk Analysis for Surgical Site Infection

Measure

Value

Risk in NPWT Cohort

0.133 (13.3%)

Risk in Conventional Cohort

0.433 (43.3%)

Relative Risk (RR)

0.308

95% Confidence Interval

0.113 – 0.836

p-value

0.022

 

Figure 4: Forest Plot of Relative Risk for Surgical Site Infection

 

Table 5: Time to Complete Epithelialization

Group

Mean ± SD (Days/Score)

p-value

NPWT Cohort

0.93 ± 0.254

0.019

Conventional Cohort

0.70 ± 0.466

 

DISCUSSION

The aim of this randomized controlled trial to investigate the clinical effectiveness of NPWT with delayed closure compared with standard practice (primary closure) in patients undergoing laparotomy for contaminated intervals. The results of the present study convincingly showed that NPWT significantly modifies the hostile wound microenvironment and promotes better postoperative outcomes. This decrease in SSI rate in NPWT group (13.3%) was pronounced compared to the conventional primary closure arm (43.3%).

 

This major decrement substantially correlates with recent high-impact surgical literature. Shen et al. (2017) studied high-risk laparotomies and showed that prophylactic negative pressure led to a statistically significant 31.0% reduction to only 16.9% SSI rates.7 Similarly, O'Leary et al. (2017) showed significant protection in abdominal surgery, with a decrease in SSI from 16% to only 4% when closed-incision NPWT was applied.8 NPWT reduces local bioburden because it continuously evacuates trapped fluid and neutralizes the hypoxic environment. Frazee et al. (2018) confirmed this mechanism, showing that closed NPWT in dirty surgical wounds achieves more rapid definitive closure and lower complication rates.9

 

In addition, the RR from our relative risk analysis was 0.308 corresponding to a staggering 69% relative risk reduction in terms of development of wound infection. This represents a level of protection similar to that reported by Danno et al. (2018) who reported a 76.2% relative risk reduction in severe peritonitis models.10 Liu et al. (2021) found that prophylactic negative-pressure dressings significantly reduce the risk of developing surgical site infection and any healthcare burden associated with emergency laparotomies.11 Singh et al. (2023) uncovered a similar pattern regarding emergency gastrointestinal perforations and noted that NPWT decreased SSI rates to 10.0%, while conventional standard care had a failure rate of 30.0%.12 It was not until the international study by the SUNRRISE Trial Study Group (2025) definitively confirmed these cumulative findings through large multicentred high-powered trials that substantial absolute risk reductions with negative pressure therapeutics became clearly visible.13 In addition to prevention of infection, we found that the NPWT arm resulted in a complete resolution of superficial SSIs and that there was a significantly accelerated rate of complete epithelialization (p = 0.019). The transition from state of chronic inflammation to proliferation is thus bridged by mechanical stabilization of the wound edges and promotion of robust angiogenesis due to sub-atmospheric pressure. Importantly, this accelerated healing was paralleled even in the presence of significant baseline leucocytosis within the NPWT cohort (p = 0.048), demonstrating that maximal systemic inflammatory response can still be overcome by means of an external intervention.

 

CONCLUSION

NPWT with delayed primary closure is a very effective, safe and biologically superior alternative in perforation peritonitis compared to immediate primary closure. It significantly decreases both the incidence and severity of surgical site infections, actively promotes epithelialization, and markedly lowers relative risk of infection without increasing seroma or dehiscence rates; thus supporting its adoption in emergency surgical protocols.

 

Recommendations

Surgical units treating high-risk, contaminated laparotomies in a healthcare setting concern NPWT and delay closure protocols as a routine modality to reduce the burden of severe wound morbidity and unify management on infection control.

 

Strengths and Limitations

The rigorous randomized controlled underpinning affords significant internal validity, but the somewhat limited cohort (n=60 people) from a single tertiary institution may limit wider epidemiological extrapolation.

 

Relevance of the Study

Provides vital, actionable clinical evidence for customizing wound survivability optimization in mega-lethal emergency general surgery presentations.

 

Authors’ Contribution

Conceptualization, data collection, statistical analysis and manuscript preparation were conducted by all authors equally.

 

Ethical Consideration

Institutional Ethics Committee approval; written informed consent was strictly obtained from all participants before enrolment.

 

Financial Support and Sponsorship

Nil.

 

Conflicts of Interest

None.

 

REFERENCES

  1. Gupta S, Kaushik R. Peritonitis-the Eastern experience. World J Emerg Surg. 2006 Apr 26;1(1):13.
  2. Graves N, Phillips CJ, Harding K. A narrative review of the epidemiology and economics of chronic wounds. British Journal of Dermatology. 2022 Aug 1;187(2):141-8.
  3. Berríos-Torres SI, Umscheid CA, Bratzler DW, Leas B, Stone EC, Kelz RR, Reinke

CE, Morgan S, Solomkin JS, Mazuski JE, Dellinger EP. Centers for disease control and

prevention guideline for the prevention of surgical site infection, 2017. JAMA surgery.

2017 Aug 1;152(8):784-91.

  1. Venturi ML, Attinger CE, Mesbahi AN, Hess CL, Graw KS. Mechanisms and clinical

applications of the vacuum-assisted closure (VAC) device: a review. American journal

of clinical dermatology. 2005 Jun;6(3):185-94.

  1. Onyekwelu I, Yakkanti R, Protzer L, Pinkston CM, Tucker C, Seligson D. Surgical wound classification and surgical site infections in the orthopaedic patient. JAAOS Global Research & Reviews. 2017 Jun 1;1(3):e022.
  2. Cohn SM, Giannotti G, Ong AW, Varela JE, Shatz DV, McKenney MG, Sleeman D,

Ginzburg E, Augenstein JS, Byers PM, Sands LR. Prospective randomized trial of two

wound management strategies for dirty abdominal wounds. ANNALS of Surgery. 2001

Mar 1;233(3):409-13.

  1. Shen P, Blackham AU, Lewis S, et al. Phase II randomized trial of negative-pressure wound therapy to decrease surgical site infection in patients undergoing laparotomy for gastrointestinal, pancreatic, and peritoneal surface malignancies. J Am Coll Surg. 2017;224(4):726–737.
  2. O'Leary DP, Peirce C, Anglim B, et al. Prophylactic negative pressure dressing use in closed laparotomy wounds following abdominal operations: A randomized, controlled, open-label trial (The P.I.C.O. Trial). Ann Surg. 2017;265(6):1082–1086.
  3. Frazee R, Manning A, Abernathy S, et al. Open vs closed negative pressure wound therapy for contaminated and dirty surgical wounds: A prospective randomized comparison. J Am Coll Surg. 2018;226(4):507–512.
  4. Danno K, Matsuda C, Miyazaki S, et al. Efficacy of negative-pressure wound therapy for preventing surgical site infections after surgery for peritonitis attributable to lower gastrointestinal perforation: A single-institution experience. Surg Infect (Larchmt). 2018;19(7):711–716.
  5. Liu DS, Cheng C, Islam R, et al. Prophylactic negative-pressure dressings reduce wound complications and resource burden after emergency laparotomies. J Surg Res. 2021;257:22–31.
  6. Singh H, Avudaiappan M, Kharel J, et al. Negative pressure wound therapy versus standard care for incisional laparotomy subcutaneous wounds in gastrointestinal perforations: A randomized controlled study. Surgery. 2023;174(2):291–295.
  7. SUNRRISE Trial Study Group; Atherton K, Brown J, et al. Negative pressure dressings to prevent surgical site infection after emergency laparotomy: The SUNRRISE randomized clinical trial. JAMA. 2025;333(10):853–863.
Recommended Articles
Research Article Open Access
Evaluation of Fetal Biometry Parameters in Predicting Gestational Age and Growth Abnormalities
2026, Volume-7, Issue 2 : 3361-3367
Research Article Open Access
Optimal Combined Anteversion in Total Hip Replacement for Indian Population: A Prospective Functional Outcome Study
2026, Volume-7, Issue 2 : 3293-3297
Case Report Open Access
Cylindroma of the Scalp: A Diagnostic Challenge on Cytology with Histopathological Correlation
2026, Volume-7, Issue 2 : 3368-3371
Research Article Open Access
Role of Fetal Echocardiography in Early Detection of Congenital Heart Diseases: A Prospective Study
2026, Volume-7, Issue 2 : 3332-3339
International Journal of Medical and Pharmaceutical Research journal thumbnail
Volume-7, Issue 2
Citations
3 Views
7 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
facebook twitter linkedin mendeley research-gate
© Copyright | International Journal of Medical and Pharmaceutical Research | All Rights Reserved